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ABSTRACT
In this thesis, multicyclic natural products and metallocene-containing polymers
were synthesized for biomedical applications.
Chapter 1 describes the overall background, the recent development of natural
product-based antimicrobial biomaterial and metallocene containing polymer for
biomedical application. Afterward, the primary research objectives of my research are
illustrated.
In chapter 2, a multicyclic natural product derived guanidine-based facially
amphiphilic homopolymers and copolymers were synthesized. Cholic acid is one of the
bile acid derivatives used to prepare facially amphiphilic moieties. A neutral polyethylene
glycol (PEG) component was used to prepare copolymers with cholic acid. Reversibleaddition fragmentation chain transfer (RAFT) polymerization technique was used to
prepare all the polymers. The self-assembly of all polymers was also investigated. Finally,
the hemolysis activity of guanidine-based facial amphiphilic polymers was measured
against red blood cells.
The synthesis of metal-containing copolymers was illustrated in chapter 3. The
diblock copolymers were prepared from cationic cobaltocenium and neutral PEG moieties.
PEG-based macro raft agent was used to make cobaltocenium containing diblock
copolymer. These diblock block copolymers can be a good candidate for biomedical
applications, especially for gene delivery.
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Finally, a summary and future directions of this dissertation research are provided
in chapter 4. In future work, some suggestions about developing new molecular biomass
with true facial amphiphilicity for antimicrobial application and metallocene based
polymers for gene delivery are given.
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CHAPTER 1
GENERAL INTRODUCTION
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1.1 Bile Acid
Bile acids are amphiphilic steroid acids found in the mammals and serve as
emulsifiers for the digestions of fat by the formation of micelles. Bile acids are produced
from the cholesterol in the liver and stored in the gallbladder.1 They are classified into two
groups within the human body based on their order of formation. Human liver cells produce
primary bile acids such as cholic acid and chenodeoxycholic acid in a multi-step pathway
via cytochrome P-450 enzyme-mediated oxidation of cholesterol.2 In the intestinal tract,
primary bile acids are partly converted to secondary bile acids, deoxycholic and lithocholic
acids by intestinal microorganism.2

Figure 1.1 Chemical structures of bile acid derivatives.
Hydroxyl groups of bile acid molecules are positioned in the concave α-face while the
multicyclic hydrocarbon structure is constituted as the convex β-face, thereby providing
the potential to achieve true facial amphiphilicity.3 Due to their unique structural features,
these acids have been primarily used in biomedical applications such as drug delivery,
prodrug formulation, and antimicrobial systems. They are abundant in nature and
accessible as biomass-derived chemicals.
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1.2 Antimicrobial Polymers
Antimicrobial resistance is now considered a major global challenge,
compromising our ability to treat infectious diseases due to the lack of discovery of novel
compounds from natural products or new classes of antimicrobials.4,5 Bacteria are capable
of acquiring resistance against antibiotics through different mechanisms such as efflux
pumps,3 chemical modification, genetic mutation, and gene transfer (Figure 1.2).6 The rise
of drug-resistant Gram-negative bacteria is a great concern given the limited number of
antimicrobial agents that can be used for such infections. Therefore, it is a crucial need to
continuously develop antibiotics with novel modes of action to face this evolving resistance
that can successfully treat bacterial infections.

A

B

Figure 1.2 (A) Mechanisms of antibiotic resistance. (B) Selective interactions between cell
membranes and cationic antimicrobial polymers.3

Antimicrobial polymers are a class of hydrophilic cationic macromolecules,
selectively destroy microorganisms such as bacteria or fungi with little or no cytotoxicity
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to mammalian cells.7 They are a class of novel antimicrobial agents that is the combination
of antimicrobial peptides (AMPs)8 and polymer disinfectants that have emerged as two
distinct fields since the 1980s.9 Host-defense antimicrobial peptides (AMPs) are
antimicrobials, act as a defense against invading pathogens including bacteria, protozoa,
yeast and fungi.10 Natural antimicrobial peptides (AMPs) are amphiphilic, combining
cationic charges and hydrophobic components, and are able to selectively bind to anionic
bacterial membranes or other anionic targets over zwitterionic human cell membranes3
(Figure 1.2).11 AMPs form an α-helix structure with positive charges arrayed on one side
and lipophilic groups aligned along the other side when comes to contact with bacteria.12,13
The global segregation of cationic and lipophilic side chains of these AMPs is also referred
to as facial amphiphilicity (i.e., separate hydrophilic and hydrophobic faces).14 This feature
(facial amphiphilicity) permits AMPs to strongly interact with biological membranes.15
However, the clinical implementation of AMPs is minimal due to their low bioavailability,
low stability, as well as in many cases nonspecific toxicity to mammalian cells. Therefore,
synthetic polymers with cationic charges, which mimic natural AMPs, have been
investigated widely to combat bacteria.

1.3 Metal Containing Polymer
Metallopolymers, are a class of metal-containing polymer with metal center
incorporated into the organic polymeric frameworks, have received significant attention
over the past few decades.16 These polymers provide desirable mechanical and processing
properties in polymeric frameworks with the combination of metal properties such as
catalytic, magnetic, and electronic properties.16 Among metallopolymers, Cationic
metallocenes (or metalloceniums) show great potential in optical, magnetic, catalytic,
4

electrochemical, and biomedical applications due to the physicochemical and processing
advantages of organic polymers with the unique sandwich structures and multifunctionality
of metallocenes.17,18 There are two major states of a metallocene: neutral metallocene and
cationic metallocenium. Neutral metallocene like ferrocene has 18 valence electrons and
can easily undergo electrophilic aromatic substitution reactions.19 But 19-e cobaltocene can
lose one electron easily to form the much more stable 18-e cobaltocenium cation, which is
incapable of undergoing electrophilic aromatic substitution reactions.20 The isoelectronic
cobaltocenium monomers and polymers show high solubility in water with the use of
hydrophilic counterion, which could be more beneficial for applications in drug delivery.21

1.4 Gene Delivery
Gene therapy has the ever-growing promise for the treatment of numerous inherited
diseases such as genetic disorders, viral infections, and cancers.22 However, the clinical
application of gene therapy for treating life-threatening illnesses remains largely
unsuccessful due to various technical obstacles.23 The lack of safe and proper vectors is
one of the main concerns. Viral and non-viral vectors have been used to deliver therapeutic
genomes to the target cells.24-25 Despite the higher transfection efficiency of viral vectors,
their biomedical applications are limited due to toxicity, immunogenicity and difficulty for
large-scale production.26 A variety of non-viral or synthetic vectors including polymers,
proteins peptides, liposomes, and exosomes have been developed over the last two decades.
Among these non-viral vectors, cationic polymers gained significant attention due to their
tunability, degradability, environmental stability, inexpensive synthesis and scalability.27
Cationic metallocene with charged metal centers can interact with negatively charged
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biomacromolecules like protein, DNA and enzymes. This bioconjugates exhibit active
endocytosis and directed nuclear delivery, which are two key steps for gene release. 28

1.5 Research Objectives
To address the current emergence of drug-resistant bacteria, the development of
new antimicrobial agents with the potent ability to kill the MDR bacteria is a significant
demand in our society. In this dissertation, new guanidine-based facial amphiphilic
polymers were prepared from a multicyclic natural product such as bile acid. Guanidinebased polymers are potent anti-microbial materials because of their selective interactions
with negatively charged bacterial cell membranes and due to the charge delocalization, the
toxicity level is very lower.29
The clinical application of gene therapy for treating or preventing life-threatening illness
remains largely unsuccessful due to various technical obstacles.27 The lack of safe and
efficient vectors is the main objective to synthesize cationic metal-containing polymer for
non-viral gene delivery. The new class of polymers as novel non-viral gene delivery
vectors were developed based on cationic metal-containing polyelectrolytes. Metal
containing polyelectrolytes with positively charged cobaltocenium can strongly bind with
the anionic phosphodiester group of a nucleic acid through electrostatic interactions.30
Cobaltocenium-containing polyelectrolytes will exhibit minimal toxicity to mammalian
cells while having a stronger binding ability to anionic macromolecules.
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CHAPTER 2
SYNTHESIS OF GUANIDINE FUNCTIONALIZED CHOLIC ACID-BASED FACIAL
AMPHIPHILIC POLYMERS
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2.1 Abstract
Guanidine-functionalized facial amphiphilic polymers are synthesized which can
be used as a powerful antimicrobial agent. Guanidine-based polymers are potent antimicrobial materials because of their selective interactions with negatively charged bacterial
cell membranes. We incorporated a guanidine functional group into facial amphiphilic
cholic acid-based macromolecular architectures to prepare a potent antimicrobial agent that
can interact preferentially with bacterial membranes. A multicyclic natural product such as
cholic acid-based polymers is modified with guanidine derivatives. Interestingly,
guanidine functionalized homopolymers form spheres and rods like nanostructures in water
from the facial amphiphilic cationic polymers via supramolecular interactions. The
hemolysis activity of homopolymers was also measured. To improve the hemolysis activity,
polyethylene glycol was used to prepare the cholic acid-based guanidine functionalized
amphiphilic diblock and random copolymers. Incorporation of polyethylene glycol exhibits
better hemolysis activity.

2.2 Introduction
The increasing prevalence of antibiotic resistance is a serious emerging challenge.
Antimicrobial resistance is an ever-increasing threat to public health due to the difficulty
to treat them with conventional antibiotics.1-3 The lack of new molecule discovery over the
last few decades has resulted in the rise of antibiotic-resistant pathogenic microorganisms.4
Among this multidrug-resistant (MDR) pathogens, Gram-negative bacteria pose more
perilous threats to human life given the limited number of antimicrobial agents that can be
used for such infections.5 The presence of dual membranes in Gram-negative bacteria acts
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as an impermeable barrier to most antibiotics and this is the driving force for the
development of new anti-microbial materials.6, 7
Antimicrobial agents such as antimicrobial peptides and antimicrobial polymers
favor a facially amphiphilic orientation during their mechanism of action. Natural
antimicrobial peptides (AMPs) are amphiphilic, shows broad-spectrum antimicrobial
activities that typically involve a membrane-disruptive mechanism.8-11

These

polymers/peptides form an α-helix structure with positive charges arrayed on one side and
lipophilic groups aligned along the other side in contact with bacterial membranes and are
referred to as facial amphiphilicity (i.e. separate hydrophilic and hydrophobic faces).12-16
In our group, we have developed several antimicrobial macromolecules utilizing natural
rosin with impressive activities.17,

18

Recently, we developed a new class of cationic

polymers with a strong antimicrobial activity using cholic acid, a derivative of bile acid
against Gram-negative bacteria, where quaternary ammonium has been used as a cationic
group.19, 20 However, the weak interaction between the quaternary ammonium and the
phosphate groups of phospholipids within cell membranes and the poor alkaline stability
are a matter of concern.21

Figure 2.1 Facially amphiphilic structure of cholic acid.
13

In recent years, guanidine-based polymers have attracted significant attention as
selective antimicrobial materials due to the selective interaction between guanidine groups
and negatively charged bacterial cell-membrane instead of electrically neutral mammalian
cell membranes, and nontoxic antimicrobial materials.9 The positive charges of the
guanidine group are delocalized over three nitrogen atoms. When guanidine is ionized it
shows a strong interaction with phosphate groups by forming hydrogen-bonded ion pairs.22
The bidentate binding between guanidine groups and phosphate groups is much stronger
than between amine groups and phosphate groups., resulting in a high bacterial rate at a
low antimicrobial concentration of guanidine-based polymers.21 Moreover, the toxicity of
this charge-delocalized guanidine is much lower than that of the charge-localized linear
amine head group. Recently, Yang and coworkers reported guanidium-functionalized nondegradable poly-norbornenes and polymethacrylates are more potent against bacteria in
vitro than their amine-functionalized counterparts.9 In order to reduce the toxicity level by
increasing the selectivity of antimicrobial polymers toward bacteria, we have synthesized
a series of guanidium-functionalized cholic-acid based cationic copolymers which can
possess intrinsic local facial amphiphilicity clustered together via a flexible
macromolecular chain.
Cholic acid is composed of large cross-sectional hydrophobic multicyclic
hydrocarbons on the convex β-face and multiple cationic charges on the concave α-face,
which provides facial amphiphilicity (Figure 2.1).19,

23, 24

Antimicrobial activity of

synthetic polymers is largely dictated by the balance of hydrophilic to hydrophobic
moieties.25 Amphiphilic copolymers comprising hydrophilic and hydrophobic segments
can self-assemble in water to form a wide variety of aggregates such as spheres, rods, and
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vesicles.26,

27

We prepared polymer nanoparticles to study the effect of cationic and

hydrophobic functionalities on antimicrobial polymers over their selectivity between
bacteria and a mammalian cell. Cholic acid and neutral polyethylene glycol (PEG)
components were chosen to make amphiphilic copolymers that can form nanosized
particles.20 We have synthesized different polymer architectures such as diblock and
random copolymers using guanidium-functionalized cholic acid-based facial amphiphilic
copolymers with a tunable PEG component to make them attractive as antimicrobial nanoobjects.
Herein, we showed three synthetic strategies to fabricate the Guanidine functionalized
cholic acid-based cationic polymers.

2.3 Experimental Section
Materials.
All chemicals were purchased from commercial sources and used as received unless
otherwise stated. Cholic acid (CA, ≥98%), 2-hydroxyethyl methacrylate (HEMA, 97%),
1,1,3,3-tetramethyl guanidine, 1-bromo ethane, 4-dimethylamino pyridine (DMAP, 99%),
Poly(ethylene glycol) methyl ether (Mn = 2000 Da) and poly(ethylene glycol) methyl ether
methacrylate (PEGMA, Mn = 500 Da)
without

further

purification.

were purchased from Sigma-Aldrich and used

1-(3-Dimethylaminopropyl)-3-ethyl

carbodiimide

hydrochloride (EDC·HCl, 98%) was purchased from TCI and used without further
purification. 6-Bromohexanoyl chloride (97%) and 1-bromo ethane were purchased from
Alfa-Aesar. 4-Cyano-4-(thiobenzylthio)pentanoic acid (CTP, 97%) was purchased from
Strem Chemicals.

Azobisisobutyronitrile (AIBN, Sigma, 98%) and solvents such as

hexane, anhydrous N, N-dimethylformamide (DMF, 99.9%), tetrahydrofuran (THF),
15

dichloromethane (DCM) were purified by standard procedures. Monomers (2methacryloyloxy)ethyl cholate (MAECA) was synthesized following our work reported
earlier.19 CDCl3 (99.9% D), D2O (99.9% D) and DMSO-d6 (99.9% D) were purchased
from Cambridge Isotope Laboratories.
Characterization
Monomer and compound purity, and polymer conversion were monitored by 300
MHz proton nuclear magnetic resonance (1H NMR) spectroscopy using Bruker Avance III
HD 300 spectrometer. Spectra were recorded in deuterated chloroform, deuterium oxide or
dimethylsulfoxide solvent in ppm (δ) with tetramethylsilane as an internal standard.
Molecular weight and molecular weight distribution of polymers were measured by gel
permeation chromatography (GPC) equipped with a Waters 1525 Binary Pump, three
Styragel columns, and a Waters 2414 Refractive Index (RI) detector. HPLC-grade THF
solvent was used as an eluent at 35 °C with a ﬂow rate of 1.0 mL/min. A series of narrowlydispersed polystyrene standards obtained from Polymer Laboratories were used to calibrate
the GPC system. GPC samples were prepared by dissolving polymers in HPLC-grade THF
at a concentration of 5-10 mg/mL and filtered by PTFE micro-filters with an average pore
size of 0.2 μm.
Dynamic light scattering (DLS)
A Zetasizer Nanoseries ZEN3690 (Malvern Instruments, Malvern, UK) instrument
was used to measure hydrodynamic diameter (Z-average) and Zeta potential of polymer
aggregates. The samples were prepared by dissolving copolymers in filtered (0.2 μm GHP
membrane filter) deionized water with a concentration of 1 mg/mL. The solutions were at

16

pH 7.0 and the measurements were carried out at 25 °C. The data processing was done
using a general-purpose algorithm provided in the Zetasizer Software. Sample
measurements were acquired in triplicate and reported as an average value.
Atomic Force Microscopy (AFM)
AFM imaging was carried out using a Multimode Nanoscope V system (Bruker,
Santa Barbara, CA). Tapping mode AFM was used to map surface topography by tapping
the surface using an oscillating tip. The measurements were achieved using commercial Si
cantilevers with a nominal spring constant and resonance frequency at 20–80 N m–1 and
230–410 kHz, respectively (TESP, Bruker AFM Probes, Santa Barbara, CA).

Synthesis of cholic acid-based homopolymer

Figure 2.2 Synthetic route of Cholic acid homopolymer.
(2-methacryloyloxy)ethyl cholate (MAECA) monomer was polymerized using a
typical RAFT polymerization technique.4 For example, MAECA (0.70 g, 1.35 mmol), 4Cyano-4-(thiobenzylthio)pentanoic

acid

(CTP)

(6.27 mg,

0.0224 mmol),

and

azobisisobutyronitrile (AIBN) (0.74 mg, 4.487 µmol) were placed in a 10 mL Schlenk flask
and dissolved in N, N-dimethylformamide (DMF) (2 mL). The mixture was performed
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with three freeze-pump-thaw cycles protected under nitrogen and immersed into a
preheated oil bath set at 70 °C. After a certain period of time, the polymerization was
quenched by exposure to air and cooled under an ice water bath. The reaction mixture was
precipitated twice into a mixture of hexane and DCM (50:50) and finally dissolved in THF
and precipitated into hexane. The polymer was dried under vacuum. The final product was
characterized by 1H NMR (Figure 2.3).

Figure 2.3 1H NMR of Cholic acid homopolymer.

Synthesis of bromoalkyl-containing cholic acid Homopolymer
CA homopolymer (300 mg) was placed in a 25 mL round bottom flask and
dissolved in anhydrous DMF (3 mL). Excess 6-bromohexanoyl chloride (3 mL) or 4bromobutanoyl chloride (3 mL) or bromoacetyl bromide (3 mL) was added to the polymer
solution dropwise at room temperature. The reaction mixture was allowed to stir at 55 °C
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for 48 h and precipitated into methanol. The product was redissolved in DCM (2 mL),
precipitated in methanol twice, and dried under vacuum. Final product was characterized
by 1H NMR (Figure 2.5).

Figure 2.4 Synthetic route of Bromo hexyl functionalized Cholic acid homopolymer.

Figure 2.5 1H NMR of Bromo hexyl functionalized Cholic acid homopolymer.

Synthesis of Cholic acid-based Guanidine-functionalized homopolymer
6-bromohexyl-modified CA homopolymer (200 mg) was dissolved in DMF (4 mL).
Then, Excess 1,1,3,3-tetramethyl guanidine (1 mL) was added to the reaction mixture and

19

stirred for 24 h at 55 °C. After cooling and concentrating the reaction mixture, the resulting
solution was precipitated in THF and centrifuged to collect the product. The product was
washed with THF and dried under vacuum. Final product was characterized by 1H
NMR (Figure 2.7).

Figure 2.6 Synthetic route of Guanidine functionalized Cholic acid homopolymer.

Figure 2.7 1H NMR of Guanidine functionalized Cholic acid homopolymer.

Quaternization of Cholic acid-based Guanidine-functionalized homopolymer
Guanidine containing CA polymer (200 mg) was dissolved in DMF (4 mL). Then,
Excess 1-bromo ethane (3 mL) was added to the reaction mixture and stirred for 24 h at

20

55 °C. After cooling and concentrating the reaction mixture, the resulting solution was
precipitated in THF and centrifuged to collect the product. The product was washed with
THF and dried under vacuum. Finally, the product was further purified by dialysis against
DI water (1 L × 3) for 24 h. The solution in the dialysis bag was collected and freeze-dried
to obtain a white product. The final product was characterized by 1H NMR (Figure 2.9).

Figure 2.8 Quaternization of Guanidine functionalized CA homopolymer.
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Figure 2.9 1H NMR of quaternization of Guanidine functionalized CA homopolymer.

Synthesis of PEGylated Raft agent
4-Cyano-4-(thiobenzylthio)pentanoic acid (CTP) (100 mg, 0.358 mmol),
Poly(ethylene glycol) methyl ether ( 644mg, 0.322 mmol) and DMAP ( 8.73mg, 0.07 mmol)
were dissolved in dry DCM (4 mL) under nitrogen atmosphere. To this solution was added
DCC (81.29 mg, 0.39 mmol) in 3 mL dry DCM drop-wise under nitrogen. Then, the
reaction mixture was stirred for 3 days at room temperature. The resulting solution was
then filtered and precipitated in Diethyl Ether. The product was washed with Diethyl Ether
and dried under vacuum. The final product was characterized by 1H NMR (Figure 2.11).

Figure 2.10 Synthesis of PEGylated RAFT agent.
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Figure 2.11 1H NMR of PEGylated RAFT agent.

Synthesis of Cholic acid and PEG-based Diblock copolymer
(2-methacryloyloxy)ethyl cholate (MAECA) monomer were polymerized using
PEG-based RAFT agent. MAECA (0.40 g, 0.76 mmol), PEG-CTP (88 mg, 0.0385 mmol),
and azobisisobutyronitrile (AIBN) (1.26 mg, 0.0076 mmol) were placed in a 10 mL
Schlenk flask and dissolved in N, N-dimethylformamide (DMF) (2 mL). The mixture was
performed with three freeze-pump-thaw cycles protected under nitrogen and immersed into
a preheated oil bath set at 70 °C. After a certain period of time, the polymerization was
quenched by exposure to air and cooled under an ice water bath. The reaction mixture was
precipitated twice into hexane. The polymer was dried under vacuum. Final product was
characterized by 1H NMR (Figure 2.13).
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Figure 2.12 Synthesis of CA-PEG diblock copolymer.
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Figure 2.13 1H NMR of CA-PEG diblock copolymer.
Synthesis of Bromine Functionalized Cholic acid and PEG-based diblock

copolymer
Post-polymerization modification was carried out by following a previously
reported method.19 Above CA-PEG Diblock copolymer (300mg) was placed in a 25 mL
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round bottom flask and dissolved in anhydrous DMF (2 mL). An excess amount of 6bromohexanoyl chloride (3 mL) was added to the polymer solution dropwise at room
temperature. The reaction mixture was allowed to stir at 55 oC for 48 hrs. After the
completion of reaction, the reaction mixture was precipitated into methanol. The product
was redissolved in DCM (2 mL), precipitated in methanol twice, and dried under high
vacuum. Final product was characterized by 1H NMR (Figure 2.15).

Figure 2.14 Bromination of CA-PEG Diblock copolymer.
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Figure 2.15 1H NMR of Brominated CA-PEG Diblock copolymer.

Synthesis of Guanidine Functionalized Cholic acid and PEG-based Diblock
copolymer
The above post-modified CA-PEG diblock copolymer (300 mg) was placed in a 25
mL round bottom flask and sealed with a rubber septum and dissolved in DMF (4 mL).
Then, Excess 1,1,3,3-tetramethyl guanidine (1 mL) was added to the reaction mixture and
stirred for 24 h at 55 °C. After cooling and concentrating the reaction mixture, the resultant
solution was precipitated in THF and centrifuged to collect the product.

The product was

washed with THF and dried under high vacuum. Finally, the product was dissolved in
deionized water, and further purified by dialysis against deionized (DI) water (1 L × 3) for
24 hrs. The solution in the dialysis bag was collected and freeze-dried to obtain a white
product. Final product was characterized by 1H NMR (Figure 2.17).
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Figure 2.16 Guanidine functionalization of CA-PEG diblock copolymer.

Figure 2.17 1H NMR of Guanidine functionalized CA-PEG Diblock copolymer.
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Synthesis of Cholic acid and PEG-based Random copolymer
CA-PEG Methacrylate monomers (MAECA and PEGMA) were copolymerized
using a typical RAFT polymerization process.20 For example, R1 (CA-PEG diblock
copolymer) was synthesized using the predetermined ratios (e. g. [Monomer] : [AIBN] :
[ CTP] = 30: 0.2: 1). MAECA (0.40 g, 0.769 mmol), PEGMA (0.384g, 0.769 mmol), CTP
(7.16 mg, 0.0256 mmol), and AIBN (0.84 mg, 5.12 µmol) were placed in a 10 mL Schlenk
flask and dissolved in DMF (1 mL). The mixture was performed with three freeze-pumpthaw cycles under nitrogen and immersed into a preheated oil bath set at 70 °C. After a
certain period of time, the polymerization was quenched by exposure to air and cooled
under an ice water bath. The reaction mixture was precipitated twice into a mixture of
hexane and DCM (80: 20) and finally dissolved in THF and precipitated into hexane.

Post polymerization modification of Cholic acid and PEG-based Random
copolymer
Post-polymerization modification was carried out by following a previously
reported method.20 For example, bromine functionalized R1 (CA-PEG random copolymer)
(400 mg) was placed in a 25 mL round bottom flask and dissolved in anhydrous DMF (2
mL). An excess amount of 6-bromohexanoyl chloride (3 mL) was added to the polymer
solution dropwise at room temperature. The reaction mixture was allowed to stir at 55 0 C
for 48 hrs. After the completion of reaction, the reaction mixture was precipitated into
methanol. The product was redissolved in DCM (2 mL), precipitated in methanol twice,
and dried under high vacuum. The reaction was confirmed by 1H NMR (Figure 2.19).
Similarly, all copolymers were modified.
28

Figure 2.18 Synthetic rout of Brominated CA-PEG Random copolymers.

Figure 2.19 1H NMR of brominated CA-PEG Random copolymers.
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Synthesis of Guanidine functionalization of Cholic acid and PEG-based
Random copolymer
The above-brominated R1 (CA-PEG random copolymer) (300 mg) was placed in a
25 mL round bottom flask and sealed with a rubber septum and dissolved in DMF (4 mL).
Then, Excess 1,1,3,3-tetramethyl guanidine (1 mL) was added to the reaction mixture and
stirred for 24 h at 55 °C. After cooling and concentrating the reaction mixture, the resultant
solution was precipitated in THF and centrifuged to collect the product.

The product was

washed with THF and dried under high vacuum. The reaction was confirmed by 1H NMR
(Figure 2.21).

Figure 2.20 Synthesis of Guanidine functionalized CA-PEG Random copolymer.
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Figure 2.21 1H NMR of Guanidine functionalized CA-PEG Random copolymer.

Quaternization of Guanidine functionalized R_CA_PEG copolymer
Quaternization of all copolymers was carried out by following a previously reported
method.8 As an example: the above guanidine functionalized R1 (CA-PEG random
copolymer) (300 mg) was placed in a 25 mL round bottom flask and sealed with a rubber
septum and dissolved in DMF (4 mL). Then, Excess 1-bromo ethane (3 mL) was added to
the reaction mixture and stirred for 24 h at 55 °C. After cooling and concentrating the
reaction mixture, the resulting solution was precipitated in THF and centrifuged to collect
the product. The product was washed with THF and dried under vacuum. Finally, the
product was further purified by dialysis against DI water (1 L × 3) for 24 h. The solution in
the dialysis bag was collected and freeze-dried to obtain a white product. The reaction was
confirmed by 1H NMR (Figure 2.23).
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Figure 2.22 Quaternization of Guanidine based CA-PEG Random copolymer.

Figure 2.23 1H NMR of Quaternized Guanidine based CA-PEG Random copolymer.

32

2.4 Results and Discussion
Polymer design and synthesis
Guanidine functionalized cholic acid-based cationic homopolymers were prepared.
First, (2-methacryloyloxy)ethyl cholate (MAEC) monomer was polymerized via reversible
addition

fragmentation

transfer

(RAFT)

polymerization

utilizing

4-cyano-4-

(thiobenzylthio)pentanoic acid as a chain transfer agent and followed by postmodification to
yield guanidine-containing polymers. Hydroxyl groups of these homopolymers were
modified through an esterification reaction with bromohexanoyl chloride. After post
modification, the peaks next to the alcohol group in 1H NMR at ~ 3.2 to 3.8 ppm shifted to
4.7 to 5.2 ppm (Figure 2.5). The methylene group next to the bromine group appears at ~
3.4 to 3.6 ppm, indicating the formation of an ester linkage.
Then the bromine groups were substituted by 1,1,3,3-tetramethyl guanidine to offer
guanidine-containing polymers. The successful synthesis was confirmed by the 1H NMR
peaks of protons on -N(CH3)2 (δ 2.8 ppm, s) and -N(CH3)2 (δ 2.9 ppm, s) (Figure 2.7).
Finally, quaternization was done by adding 1-bromo ethane. The appearance of an intense
peak at ~ 3.0 ppm for all the methyl groups of guanidine and bromoethane and a peak at ~
3.2 ppm for the methylene group of bromo ethane in 1H NMR (Figure 2.9) spectra
confirmed the formation of quaternary guanidine-containing polymers. A series of
different molecular weight polymers H1, H2, H3 and H4 (Mn = 7,000-12,000 g mol-1) were
further prepared (Table 2.1). The molecular weight of all four cholic-acid polymers was
controlled with low dispersity as determined by Gel Permeation Chromatography (GPC).
To improve the solubility in water, a series of amphiphilic copolymers bearing
hydrophilic PEG and facial amphiphilic bile acid derivatives were synthesized via
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reversible addition−fragmentation chain-transfer (RAFT) polymerization by following a
recently reported method.27 The random copolymer was made where linear poly (ethylene
glycol) methyl ether (PEGMA, Mn = 500 Da) was chosen as a neutral hydrophilic block.
Hydroxyl groups on the cholic acid (CA) moiety of the copolymers were functionalized to
introduce Quaternized Guanidine groups in the copolymers via esterification with
bromohexanoyl chloride, then substitution with 1,1,3,3-tetramethyl guanidine and
quaternization with 1-bromo ethane (Figure 2.22). according to a reported procedure.20 To
study the influence of hydrophilicity on the copolymer self-assembly, we prepared three
cholic acid and PEG-based random copolymers R1, R2 and R3 (Table 2.1) with different
fractions of PEG (20−40% molar ratio). The polymerization was well controlled with a
molecular weight in the range of Mn = 9,000− 18,000 Da and low dispersity (Đ = 1.19−1.6),
as determined by gel permeation chromatography (GPC). The post-polymerization
modification was confirmed by 1HNMR (Figure 2.19) the peaks at ∼3.6−3.8 ppm for −CH
on the tetracyclic rings, adjacent to the alcohol group, shifted to 4.7−5.2 ppm). The
appearance of a peak at ∼3.5 ppm for the methylene group confirms the presence of
PEG. The incorporation of guanidine was confirmed by the presence of a peak at ∼2.5
ppm for the protons on -N(CH3)2 (Figure 2.21).
In addition to the random copolymers, a diblock copolymer was also synthesized
in order to improve the solubility of the polymers in water and the effect of polymer
architecture on the antimicrobial activity. Linear PEG (Mn = 2000 Da)

was modified to

PEG-based RAFT agent (PEG-CTP) and used to polymerize cholic acid-based
methacrylate monomer (2-methacryloyloxy)ethyl cholate (MAECA), via reversible
addition−fragmentation chain transfer (RAFT) polymerization and followed by
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postmodification to yield guanidine functionalized copolymer D (Figure 2.16), according
to a method recently reported.20
Table 2.1 Guanidine functionalized cholic acid-derived polymers characterized by GPC.
Polymer

Cholic acid

PEG content

Mn (g mol-1)

Ð

content (%)
H1

100

7,000

1.09

H2

100

7,200

1.10

H3

100

9,000

1.16

H4

100

12,000

1.19

D

80

20

12,000

1.12

R1

80

20

12,500

1.19

R2

70

30

9,000

1.21

R3

60

40

18,000

1.6

Self-Assembly Behavior
Recently, we showed that facial amphiphilicity of cholic acid moiety can induce
the self-assembly of the amphiphilic polymers.19,
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To investigate the self-assembly

behavior of homopolymer, dynamic light scattering (DLS) experiment was performed in
an aqueous solution of guanidine factionalized homopolymer. The hydrodynamic diameter
(Dh) of H3 and H4 polymers are around 70 nm and 120 nm respectively, confirming that
these copolymers formed aggregates in aqueous solution. The size of the aggregation
increases with the molecular weight.
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Figure 2.24 DLS size distribution graph of homopolymers with a concentration of 1
mg/mL.
Then the morphology formed by different homopolymers in water was visualized
by atomic force microscopy (AFM). The aqueous solution of polymers was incubated at
37 oC temperature for one day; then the solution was drop cast onto a silicon wafer and
dried at room temperature for AFM imaging. A spherical morphology was observed from
the H3 homopolymer solution and, rod-like nanostructures were formed from the H4
homopolymer (Figure 2.25). The average size of the spherical aggregates is around 200
nm and rods are around 220 nm length with 90 nm diameter. In the sphere, the hydrophobic
moiety of cholic acid forms the core by hydrophobic integration and the quaternized
guanidine stays on the corona.28
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Figure 2.25 AFM images of homopolymers H3 and H4. AFM images were taken from
an aqueous solution at a concentration of 5 mg/mL.
Hemolysis Activities
The hemolysis activity of cholic based guanidine functionalized cationic
homopolymers was evaluated by measuring hemoglobin release from mouse red blood
cells (RBCs) at various concentrations.29 The HC50, the concentration that causes 50%
hemolysis of RBCs, is measured for H3 and H4 homopolymers. The results showed that
the guanidine functionalized cholic acid homopolymers exhibit some toxicity. This is
maybe due to the presence of a large four fused-ring structure and the methyl /ethyl groups
in the guanidine derivative.30 To overcome these issues, neutral PEG was incorporated into
the guanidine-based polymers to increase the hydrophilicity of bile acid-based copolymers.
Interestingly, we observed that diblock copolymer (D) showed very low hemolysis activity
(Figure 2.26). The HC50 value for diblock copolymer is >1000 µg/mL, demonstrating that
the PEG can increase the biocompatibility by increasing the hydrophilicity of the
guanidine-based diblock polymer.
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Figure 2.26 Hemolysis activity of polymers measured by hemoglobin release from mouse
RBCs at various concentrations.

2.5 Conclusions
In summary, we synthesized guanidine functionalized cholic acid based amphiphilic
homopolymers, diblock, and random copolymers. These facial amphiphilic polymers can
be a potential antimicrobial agent against both Gram-positive and Gram-negative bacteria.
Guanidine functionalized homopolymers form spheres and rod-shaped aggregates.
Incorporation of PEG improved the hemolysis activity of guanidine functionalized cholic
acid

polymers.

Guanidine

functionalized

biocompatibility than homopolymers.
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diblock

copolymers

showed

better
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CHAPTER 3
SYNTHESIS OF COBALTOCENIUM CONTAINING POLYMERS FOR GENE
DELIVERY
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3.1 Abstract
Gene therapy is an attractive therapeutic option in order to correct disease at the
genetic level by replacing abnormal genes using exogenous DNA. Polymers are synthetic
gene delivery vectors that possess the ability to deliver genetic material to target cells.
Metal-containing polymers are excellent candidates for drug delivery due to their unique
combination of organic and inorganic components in one macromolecular system. Cationic
polymers neutralize the negative charge on plasmid DNA resulting in the formation of
nanoscale polymer-DNA complexes (polyplexes). However, the use of cobaltocenium for
gene delivery vehicles is still unexplored. We have synthesized cationic cobaltocenium
based polymers with PEG which can be a potential candidate for gene delivery because
they can actively bind with DNA by electrostatic interactions and are non-toxic to
mammalian cells.

3.2 Introduction
Nucleic acid-based therapeutics has gained extensive attention over the past few decades
due to their promising approach for the treatment of many untreatable, life-threatening and
chronic diseases, ranging from genetic disorders to cancer.1 However, there are no potentially
active nucleic acid loaded drugs realized clinically due to their delivery challenges.2 Viral and
non-viral vectors are used to transport the nucleic acid-based therapeutics including plasmid
DNA and small interfering RNA.3 Though viral gene delivery vectors are more operative for
higher transfection efficiency, their medical applications are limited by immunogenicity,
toxicity, and difficulties of large-scale production as well as high manufacturing costs.4
Therefore,our primary focus was to design the effective non-viral vectors that can
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circumvent these problems for efficient gene transfection. These non-viral vectors need to
prevent potential degradation of the polyplexes by serum endonucleases in the
physiological fluids and the extracellular space needs to extravasate from the bloodstream
to reach target tissues and facilitate cell entry via endocytosis.5 In endocytosis, vectors have
to reach into the endocytic vesicles. Another critical challenge of the non-viral vectors is
the endosomal escape for delivering nucleic acid therapeutics.6
One of the promising non-viral vectors cationic polymers attracted much popularity
due to their limited immunogenicity and straightforward synthesis, as well as their
amenability to structural modification.7 Cationic polymer forming a complex with DNA
through electrostatic interactions are called polyplex.8 Numerous cationic polymers have
been explored so far, Poly(ethyleneimine) (PEI) is one of the efficient gene carriers due to
their binding ability with DNA using their primary amine.9 Despite the tremendous success
of PEI under in vitro conditions, their in vivo application was limited due to their
cytotoxicity and instability of polyplex under the physiological environment.10 Most of the
existing cationic polymers are cytotoxic and unstable under physiological conditions and
cannot overcome the other barriers due to their weak interactions with DNA. Therefore, it
is an urgent need to develop nontoxic cationic polymer vectors with a high binding affinity
towards DNA for overcoming undesirable effects.
Metal-containing polymer has gained significant attraction due to its emerging
biomedical applications.11 Metallopolymers especially cobaltocenium based polymers can
be potential candidates for nucleic acid (DNA/RNA) delivery due to their less cytotoxicity,
redox properties and charged state as well as their unique interaction with DNA/RNA.11
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Cobaltocenium cation can bind strongly to negatively charged DNA/RNA through
electrostatic interactions.12
Coating the surface of nanoparticles with polyethylene glycol (PEG), or
“PEGylation”, is a commonly used method for improving the efficiency of drug and gene
delivery to the target cells.13 Polyethylene glycol (PEG) is the most widely used “stealth”
polymer in the drug delivery field, due to its long history of safety in humans.14 Due to its
hydrophilic nature, PEG coat the surface of the therapeutic with an inert polymer which
changes the positive surface to neutral surface and resist the interaction of polycation with
the components of the bloodstream.15 Therefore, it increases colloidal stability and reduces
the toxicity of cationic polymer.15 Herein, we have synthesized the cationic cobaltocenium
based polymer with a certain amount of PEG to deliver the nucleic acid-based therapeutics.

3.3 Experimental Section
Materials
Cyclopentadiene (95%, Acros) dimer was distilled via a 30cm column to obtain
cyclopentadiene unimer, Sodium (Sigma-aldrich), n-BuLi solution in hexane, 4(dimethylamino)pyridine (99%, DMAP), 2-aminoethyl methacrylate hydrochloride (90%),
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide

hydrochloride

(EDC-HCl,

98%),

Tetrabutylammonium chloride (TBACl) salt was purchased from Sigma Aldrich and used
directly. 2, 2-Azobisisobutyronitrile (AIBN), Cobalt (II) bromide (anhydrous, Alfa Aesar),
Sodium hexafluorophosphate (98%, Oakwood Products) were used as received.
Poly(ethylene glycol) methyl ether (Mn = 2000 Da), poly(ethylene glycol) methyl ether
methacrylate (PEGMA, Mn = 500 Da)

and 4-Cyano-4-(thiobenzylthio)pentanoic acid

(CTP, 97%) was purchased from Strem Chemicals.
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Characterization
Monomer and compound purity, and polymer conversion were monitored by 300
MHz proton nuclear magnetic resonance (1H NMR) spectroscopy using Bruker Avance III
HD 300 spectrometer. Spectra were recorded in deuterated chloroform, deuterium oxide or
dimethylsulfoxide solvent in ppm (δ) with tetramethylsilane as an internal standard.
Synthesis of trimethylsilylethynylcobaltocenium hexaflurophosphate (TMSCoPF6)
Trimethylsilylethynylcobaltocenium

hexaflurophosphate

was

prepared

by

following a recently reported method by our group.31 A 500 mL round-bottom flask was
charged with a magnetic stirring bar and 200 ml of dry THF, 2.40 mL of (trimethylsilyl)
acetylene (17 mmol) under protection from the air by a nitrogen atmosphere. The mixture
was cooled using dry ice/acetone and 6.28 mL (15.6 mmol) of n-BuLi solution was added.
It was let to stir for 50 minutes followed by the addition of 5 g of cobaltocenium
hexafluorophosphate (14.9 mmol). The cobaltocenium hexafluorophosphate was
synthesized according to the literature.16,17 The reaction mixture was slowly cooled to room
temperature to let it react further. There was a color change from yellow to rusty red which
is because of the nucleophilic addition. The solvent was removed and passed through an
alumina column using hexane. After removing hexane in vacuo 3.5 g of solid
cobaltocenium was obtained which was then further dissolved in 150 mL of dry DCM.
6.15 g of triphenylcarbenium hexafluorophosphate was added to the stirring solution and
let it react in dark condition for 15 minutes. Then, the reaction mixture was filtered and
washed with ether and water until filtrate came off clear. The obtained solid was dried in
vacuum to give 60 % (5.08 g) overall yield.

48

Figure 3.1 Synthetic route of TMSCoPF6.
Synthesis of carboxycobaltocenium hexaflurophosphate
Carboxycobaltocenium hexaflurophosphate was prepared by a recently reported
method.31 For example, 2g of TMSCoPF6 (4.65 mmol) was dissolved in 90 mL of
acetonitrile and sodium fluoride (4.65 mmol) was added. Then, an aqueous potassium
permanganate solution (2.7 equivalent, 12.56 mmol in 150mL water) was added into it.
The reaction mixture was refluxed for 4 hrs at 80 °C. The resulting mixture was then
filtered and washed with hot water. The filtrate was concentrated in a vacuum at 100oC and
let it cool down. Hexafluorophosphoric acid (1.3 equivalent, 6.05 mmol) was added and
the product was allowed to crystallize overnight. Next, the obtained yellow powder was
filtrated, washed with ice-cooled water and dried in vacuum to give 70 % yield (1.30 g).

Figure 3.2 Synthetic route of carboxycobaltocenium hexaflurophosphate.
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Synthesis of 2-Cobaltoceniumamidoethyl methacrylate hexafluorophosphate
(CoAEMAPF6)
An amidation reaction was performed31 to synthesize CoAEMAPF6. 4g of
cobaltoceniumcarboxylic acid hexafluorophosphate (1.0 equiv, 10.58 mmol), 2.28g of 2aminoethyl methacrylate hydrochloride (1.3 equiv, 13.76 mmol), and 0.38 g of 4(Dimethylamino) pyridine (0.3 equiv, 3.18 mmol) were dissolved in 40 mL dry DCM and
the solution was cooled to 00C. A solution of EDC-HCl (2.64 g, 1.3 equiv 13.76 mmol)
was then slowly added into the previously cooled solution. Then, dry triethylamine (3.2,
2.5 equiv, 26.44 mmol) was immediately added into the reaction mixture and stirred for 4
hours at room temperature. The solution was then extracted by saturated sodium
hexafluorophosphate aqueous solution three times to remove unreacted starting materials.
The organic phase was condensed and precipitated into diethyl ether. 3 g of yellow solids
were collected and dried under vacuum overnight.

Figure 3.3 Synthesis of CoAEMAPF6 monomer.
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Figure 3.4 1H NMR of CoAEMAPF6.

Synthesis of PEGylated Raft agent

Figure 3.5 Synthesis of PEGylated RAFT agent.
4-Cyano-4-(thiobenzylthio)pentanoic acid (CTP) (100 mg, 0.358 mmol), Poly(ethylene
glycol) methyl ether ( 644mg, 0.322 mmol) and DMAP ( 8.73mg, 0.07 mmol) were
dissolved in dry DCM (4 mL) under nitrogen atmosphere. To this solution was added DCC
(81.29 mg, 0.39 mmol) in 3 mL dry CH2Cl2 drop-wise under nitrogen. Then, the reaction
mixture was stirred for 3 days at room temperature. The resulting solution was then filtered
and precipitated in Diethyl Ether. The product was washed with Diethyl Ether and dried
under vacuum. Final product was characterized by 1H NMR (Figure 3.6).

51

c

d
e

b
a

a
d

a

b

c

Figure 3.6 1H NMR of PEGylated RAFT agent.

Synthesis of Cobaltocenium-PEGMA Diblock copolymer
Cobaltocenium monomer CoAEMAPF6 and PEGMA were copolymerized using a
typical RAFT polymerization process by using the predetermined ratios (e. g. [Monomer] :
[AIBN] : [ CTP] = 60: 0.3: 1). CoAEMAPF6 (0.30 g, 0.613mmol), PEGMA (0.205g, 0.411
mmol), CTP (3.78 mg, 0.0171mmol), and AIBN (0.56 mg, 3.43 µmol) were placed in a 10
mL Schlenk flask and dissolved in DMF (1 mL). The polymerization was started by heating
the mixture at 90°C. Samples were taken out periodically to check the monomer conversion.
Once the desired conversion was reached, the polymerization reaction was quenched by
exposure to air. The reaction mixture was then precipitated in cold DCM three times and
vacuum dry overnight.
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+

Figure 3.7 Synthesis of P (CoAEMAPF6 and PEGMA) diblock copolymer.

Figure 3.8 1H NMR of P (CoAEMAPF6 and PEGMA) diblock copolymer.
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Synthesis of P(PEG-PCoAEMAPF6) diblock copolymer
Cobaltocenium monomer CoAEMAPF6 monomer were polymerized using PEGbased RAFT agent by using the predetermined ratios (e. g. [Monomer] : [AIBN] : [ CTP]
= 20: 0.3: 1). CoAEMAPF6 (0.30 g, 0.62 mmol), PEG-CTP (70.46mg, 0.03 mmol), and
azobisisobutyronitrile (AIBN) (1.52mg, 0.0094 mmol) were placed in a 10 mL Schlenk
flask and dissolved in N, N-dimethylformamide (DMF) (4 mL). ). The polymerization was
started by heating the mixture at 90°C. Samples were taken out periodically to check the
monomer conversion. Once the desired conversion was reached, the polymerization
reaction was quenched by exposure to air. The reaction mixture was then precipitated in
cold DCM three times and vacuum dry overnight. The final product was characterized by
1

H NMR (Figure 3.10).

Figure 3.9 Synthesis of P(PEG-PCoAEMAPF6) diblock copolymer.
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Figure 3.10 1H NMR of P(PEG-PCoAEMAPF6) diblock copolymer.

Ion-exchange of P(PEG-PCoAEMAPF6) diblock copolymer
1 mL of PEGylated PCoAEMAPF6 polymer solution (30 mg/mL in acetonitrile)
was slowly added into 5 mL tetrabutylammonium chloride salt solution (40mg/mL in
acetonitrile) under vigorous stirring. After stirring for 3~5 minutes, the precipitated
polymers were collected and washed by acetonitrile three times to remove PF6 – anions and
excess tetrabutylammonium salts. The solid polymers were then vacuum-dried and
collected.
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Figure 3.11 Ion exchange of P(PEG-PCoAEMAPF6) diblock copolymer.

Figure 3.12 19F NMR of P(PEG-PCoAEMAPF6) diblock copolymer.

3.4 Results and Discussion
Synthesis and Characterization
We have synthesized pure monosubstituted cobaltocenium monomer to prepare
side-chain cobaltocenium containing polymers. The statistical reaction was done by using
unsubstituted cobaltocenium and organolithium reagents were followed as shown in
Figure 3.13.18,19 This method consists of facile nucleophilic addition and selective hydride
abstraction of endo-proton followed by the oxidative cleavage by potassium permanganate
with an overall yield of around 81%.

56

Figure 3.13 Synthetic route of carboxycobaltocenium hexaflurophosphate.
The monosubstituted cobaltocenium acid was reacted with 2-aminoethyl methacrylate
hydrochloride in acetonitrile with EDC as a coupling agent, as shown in Figure 3.3. The
protons of –CH2 groups at 3.5 ppm and 4.36 ppm and amide proton at 8.3 ppm showed the
successful synthesis of monomer, as shown in Figure 3.4. The peaks at 5.67 ppm and 6.12
ppm corresponded to the vinyl protons of methacrylate monomer.
Methacrylate monomer of cobaltocenium (CoAEMAPF6) and Poly(ethylene glycol)
methyl ether methacrylate was used to make block copolymer via reversible additionfragmentation chain transfer (RAFT) polymerization (Figure 3.7). The ratio of [Monomer]
/ [RAFT] was adjusted to achieve the target molecular weight (15,000 g/mol). The
polymerization was done by targeting 50% monomer conversion and the conversion was
checked periodically by comparing the vinyl proton peaks with cobaltocenium peak.
Compared to the 1H NMR spectrum of monomer, the vinyl protons disappeared, and a new
broad peak showed up at 1.5 ppm in the 1H NMR (Figure 3.8). As cobaltoceniumcontaining polymers cannot be characterized by GPC due to the interaction between the
cationic polymers and stationary phase of columns, end group analysis was used to confirm
the final degree of polymerization.20, According to recent work by our group,
cobaltocenium-containing polymers depend on the counterions.31 Polymers with different
anions show different hydrophobicity such as polymer with PF6
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-

and BPh4

-

are

hydrophobic and polymers with inorganic counterions like chloride, bromide are extremely
hydrophilic. Thus, we attempted to synthesize water-soluble polymers through the ion
exchange phenomenon so that we can use these polymers for biological applications.
Tetrabutylammonium chloride (TBACl) was used to carry out the anion exchange.
However, no precipitation was found when PCoAEMAPF6-PEGMA solution in acetonitril
was added into the salt solution. Therefore, we have tried another effective synthetic
strategy to prepare linear PEG-based cobaltocenium block copolymer.

Figure 3.14 Synthetic route of P(PEG-PCoAEMAPF6) diblock copolymer.
PEG-based macro chain transfer agent was prepared by the esterification between 4Cyano-4-(thiobenzylthio)pentanoic acid (CTP) and Poly(ethylene glycol) methyl ether
(Mn= 2000 Da). This PEG-RAFT agent was used to polymerize methacrylate monomer of
cobaltocenium (CoAEMAPF6). The ratio of [Monomer]:[RAFT] was 20:1 to achieve
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target molecular weight 10,000 g/mol. The polymerization was done by targeting 85%
monomer conversion and the degree of polymerization was 20. Final molecular weight was
6,000 g/mol. The reaction was confirmed by the 1HNMR (Figure 3.10). In the 1H NMR
the appearance of a new peak at around 3.5 ppm for the methylene group and a peak at 3.3
ppm for the methyl group of PEG-RAFT agent confirmed that the reaction was successful.
To make the polymer water-soluble we performed the ion exchange of P(PEGPCoAEMAPF6) diblock copolymer. Tetrabutylammonium chloride (TBACl) was used to
carry out the anion exchange. P(PEG-PCoAEMAPF6) diblock copolymer solution in
acetonitrile was precipitated in the salt solution (10 times molar ratio of cobaltocenium
moiety) under vigorous stirring. The precipitated polymer was washed three times with a
salt solution and finally by acetonitrile to remove any left-over polymer. Fluorine NMR
(19F) (Figure 3.12) confirmed the complete ion-exchange. After the ion-exchange, the
resulting polymer was not soluble in acetonitrile but soluble in water.

3.5 Conclusions
In summary, we have synthesized linear PEG-based cobaltocenium block copolymer
after preparing the PEG-based macro chain transfer agent which can be a stable
nanoparticle complex with DNA/RNA. We have also synthesized cobaltocenium monomer
and Poly (ethylene glycol) methyl ether methacrylate-based cationic polymer through ion
exchange procedure that needs to be improved for this synthetic strategy.
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CHAPTER 4
SUMMARY AND OUTLOOK
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4.1 Dissertation Summary
There were two major goals of this dissertation. First, to develop a novel
antimicrobial polymer with repeat units possessing local facial amphiphilicity from a
multicyclic natural product such as cholic acid. Guanidine functional group was
incorporated into facial amphiphilic cholic acid-based macromolecular architectures to
synthesize different polymer architectures such as diblock and random copolymers, which
can be a potent anti-microbial material of their selective interactions with negatively
charged bacterial cell membranes. In this approach, a neutral polyethylene glycol (PEG)
component was chosen to prepare polymer nanoparticle with cholic acid to study the effect
of cationic and hydrophobic functionalities on antimicrobial polymers over their selectivity
between bacteria and a mammalian cell. The hemolysis data showed that PEG can increase
the biocompatibility by increasing the hydrophilicity of the guanidine-based diblock
polymer.
The second goal was to prepare non-toxic gene delivery vectors by copolymerizing
the cobaltocenium and PEG that can form a safe and stable polyplex with DNA or RNA.
Linear PEG was incorporated into the cationic cobaltocenium by preparing a PEG-based
macro-RAFT agent which can condense DNA through electrostatic interaction to build the
complex (called polyplex) core. Cationic cobaltocenium was polymerized with a certain
amount of PEG so that the PEG segment can surround the polyplex like a corona and
prevent the nanoparticles from precipitation by increasing the colloidal stability and reduce
the adsorption of serum.
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4.2 Future Work
Antimicrobial biomaterial development using hydrocarbon-rich biomass such as
rosin and bile acids has more avenues for future developments to make them more effective
antimicrobial agents with low toxicity. Guanidine-based polymers, as one of the
antimicrobial polycations, show excellent antimicrobial properties, which stem from the
special structure of guanidine. Guanidine is protonated and positively charged under
physiological conditions. The guanidine derivative with the multicyclic natural product
(cholic acid) derived facial amphiphilicity by post polymerization modification has been
developed as a potent antimicrobial agent. New molecular biomass with true facial
amphiphilicity can be explored in the future. Only guanidine-based polymers can be
synthesized by the conversion of guanidine in the side chain with bile acid polymers or by
the direct polymerization of guanidine-functionalized monomers. The antimicrobial
activity of all newly synthesized polymer will also be evaluated.
To improve transfection efficacy by controlling polymer topology and polycation
contents bioreducible disulfide bonds will be inserted from cystamine into the
cobaltocenium based polymer. A couple of simple amidification reactions will yield
cystamine containing a macro raft agent. The pEG-based macro chain transfer agent will
also be prepared by coupling reaction from methoxy polyethylene glycol amine and 4cyanopentanoic acid dithiobenzoate (CTA).2 PEG-CTA will be used to polymerize 2cobaltocenium amidoethyl methacrylate hexaflurophosphate (CoAEMAPF6) in the
presence of AIBN. Cobaltocenium based homopolymers are almost non-toxic. Hemolysis
study will be conducted to evaluate the cytotoxicity of the cobaltocenium containing
copolymers The in vitro gene delivery efficiency of cobaltocenium based polyplexes will
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also be tested in different cancer cell lines (HeLa and KB cervical carcinomas, A549 and
HCC1299 lung carcinoma, and Z310 choroidal epithelial cells) using a luciferase reporter
plasmid.
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